News and Trends 23 May 2023
Vicore reports new data from idiopathic pulmonary fibrosis study
Vicore Pharma Holding AB (publ), has announced an updated interim analysis of its AIR phase 2a trial with C21 in idiopathic pulmonary fibrosis (IPF). With 51 patients enrolled, the data…